Prostate cancer (metastatic, castration resistant) - abiraterone (following cytoxic therapy): comments on the appraisal consultation
To follow
Janssen
The Prostate Cancer Charity
Prostate Cancer Support Federation
British Association of Urological Surgeons
British Uro-Oncology Group
Cancer Research UK
Royal College of Physicians
Department of Health
NHS Hertfordshire
NHS Bradford and Airedale
Commissioning Support Appraisals Service
National Collaborating Centre for Cancer
Institute of Cancer Research
This page was last updated: 18 May 2012